JOMPAC
Journal of Medicine and Palliative Care

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

eISSN: 2717-7505
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Comparison of procalcitonin, C-reactive protein, white blood cell counts and hemogram subparameters in community acquired pneumonia patients
Abstract
Aims: Pneumonia is a clinically and radiologically detected inflammation of the lungs. Most of the pneumonia patients are community-acquired pneumonia cases. Hemogram and C-reactive protein (CRP) are commonly used to support diagnosis and follow-up of treatment. Procalcitonin is less accessible and expensive. And the use of hemogram subparameters is not very common. The aim of this study was to research the relationship between procalcitonin, CRP, White Blood Cell count (WBC) and hemogram subparameters in patients with CAP and the efficacy of new hematologic rates in differential diagnosis.
Methods: Patients who were diagnosed with community acquired pneumonia by applying to the chest diseases outpatient clinic of our hospital were retrospectively analyzed. 67 patients who were clinically and radiologically diagnosed without noticing male or female were included in our study. Anamnesis data and co-morbidities of the cases were questioned. Procalcitonin, CRP and hemogram (platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) were calculated and WBC value was examined) were recorded. The obtained data were evaluated statistically and compared in terms of variables.
Results: The mean age of our patients was 57 (18-71) years; there were 41 (61.19%) female and 26 (38.81%) male patients. 36 (53.73%) of our patients had chronic diseases; 21 (31.34%) had heart disease, 23 (34.32%) had diabetes, and 6 (8.95%) had kidney failure. Patients; 48 (71.64%) procalcitonin, 56 (83.58%) CRP, 38 (56.71%) WBC, 52 (77.61%) NLR, 34 (50.74%) PLR and 38 (56.71%) MLR values were high. Procalcitonin, CRP and NLR values were significantly higher than other subparameters. The CRP and NLR values of patients with an additional chronic disease were higher than patients without co-morbidities. In the correlation analyses, there was a strong correlation between procalcitonin, CRP and NRL, but the correlation between the others was not significant. (p<0.001).
Conclusion: Our study shows NLR from hemogram subparameters can be used safely in CAP patients. Procalcitonin is expensive test for. Considering that Procalcitonin is not available in primary care family health centers and CRP is found in some family health centers, the calculated use of NLR will support the diagnosis. Using fewer examinations in secondary and tertiary health facilities is also valuable in terms of reducing health costs.

Keywords : Pneumonia, NLR, procalsitonin, CRP

Download Article


1. T&uuml;rk Toraks Derneği. Erişkinlerde toplumda gelişen pn&ouml;monilertanı ve tedavi uzlaşı raporu. Buluş;2021.
2. Almiral J, Bolibar I,Vidal J, et al. Epidemiology of communityacquired pneumonia in adults: apopulation -based study. EurRespir J. 2000;15(4):757-763.
3. Theilacker C, Sprenger R, Leverkus F, et al. Population-basedincidence and mortality of community-acquired pneumonia inGermany. PLoS One. 2021;16(6):e0253118.
4. T.C. Sağlık Bakanlığı, Refik Saydam Hıfzıssıhha MerkeziBaşkanlığı Hıfzıssıhha Mektebi M&uuml;d&uuml;rl&uuml;ğ&uuml;, Başkent &Uuml;niversitesiUlusal Hastalık Y&uuml;k&uuml; ve Maliyeti Etkinlik Projesi, 2004 (www.toraks.org.tr).
5. Wunderink RG. Community-acquired pneumonia. In:Cohen J, Powderly, Opal SM, eds. Infectious Diseases. 4th ed.Elsevier;2017:251-257.
6. Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalizedwith pneumonia in the United States: incidence, epidemiology,and mortality. Clin Infect Dis. 2017;65(11):1806-1812.
7. &Ouml;zl&uuml; T, B&uuml;lb&uuml;l Y, &Ouml;zsu S. Ulusal verilerle toplumda gelişenpn&ouml;moniler. T&uuml;berk&uuml;loz Toraks Derg. 2007;55(2):191-212.
8. &Ouml;zl&uuml; T. Toplum k&ouml;kenli tipik pn&ouml;moniler. Sendrom. 1996;8(6):41-46.
9. Campbell GD. Overview of community-acquired pneumo-nia: prognosis and clinical features. Med Clin North Am.1994;78(5):1035-1048.
10. Berg AS, Inchley CS, Fjaerli HO, et al. Clinical features andinflammatory markers in pediatric pneumonia: a prospectivestudy. Eur J Pediatr. 2017;176:629-638.
11. Florin TA, Ambroggio L. Biomarkers for community-acquiredpneumonia in the emergency department. Curr Infect Dis Rep.2014;16:451. doi.org/10.1007/s11908-014-0451-8
12. Sintes H, Sibila O, Waterer GW, Chalmers JD. Severity assesmenttools in CAP. Eur Respir Monogr. 2014;63:88-104.
13. Ewig S, Bauer T, Richter K, et al. Prediction of in-hospital deathfrom community-acquired pneumonia by varying CRB-agegroups. Eur Respir J. 2013;41(4):917-922.
14. Hohenthal U, Hurme S, Helenius H, et al. Utility of C-reactiveprotein in assessing the disease severity and complicationsof community-acquired pneumonia. Clin Microbiol Infect.2009;15(11):1026-1032.
15. Van Vugt SF, Broekhuizen BDL, Lammens C. Use of serum C reactiveprotein and procalcitonin concentrations in addition to symptomsand signs to predict pneumonia in patients presenting to primarycare with acute cough: diagnostic study. BMJ. 2013;346:f2450.
16. Abers MS, Musher DM. Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics. QJM Int J Med.2014;107(7):595-596.
17. Lowsby R, Gomes C, Jarman I, et al. Neutrophil to lymphocytecount ratio as an early indicator of blood stream infection in theemergency department. Emerg Med J. 2015;32(7):531-534.
18. de Jager CP, Wever PC, Gemen EF, et al. The neutrophil-lymphocyte count ratio in patients with community-acquiredpneumonia. PLoS One. 2012;7(10):e46561.
19. &Uuml;&ccedil;sular F, Polat G, Karadeniz G, et al. Predictive value of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio inpatients with hypersensitivity pneumonia. Sarcoidosis Vasc DiffusLung Dis. 2020;37(4):e2020012.
20. Şahin F, Feyza Aslan A, Ko&ccedil; Kara&ccedil;ar C. Which is the mosteffective inflammatory marker in the diagnosis, severity andtreatment follow-up of patients with pneumonia? Eur Resp J.2019;54(Suppl 63):PA4541.
21. Omran A, Awad H, Ibrahim M, et al. lung ultrasound andneutrophil lymphocyte ratio in early diagnosis and differentiationbetween viral and bacterial pneumonia in young children.Children. 2022;9(10):1457.
22. Cheng W, Chen L, Yu H, et al. Value of combining of the NLR andthe fibrinogen level for predicting stroke-associated pneumonia.Neuropsychiatric Disease and Treatment. 2021;17:1697-1705.
23. Ng WWS, Lam SM, Yan WW, Shum HP. NLR, MLR, PLRand RDW to predict outcome and differentiate between viraland bacterial pneumonia in the ıntensive care unit. Sci Rep.2022;12(1):15974.
24. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present andfuture perspectives. Bratisl Lek Listy. 2021;122(7):474-488.
25. Damar &Ccedil;akırca T, Torun A, &Ccedil;akırca G, Portakal RD. Role of NLR,PLR, ELR andCLR in differentiating COVID-19 patients withand without pneumonia. Int J Clin Pract. 2021;75(11):e14781.
26. Koval D, Bielosludtseva K. Neutrophil-to-lymphocyte ratio(NLR) as a marker of COVID-19-associated pneumoniaprogression. Eur Resp J. 2022;60(Suppl 66):3533.
27. Curbelo J, Rajas O, Arnalich B, et al. Neutrophil count percentageand neutrophil-lymphocyte ratio as prognostic markers inpatients hospitalized for community-acquired pneumonia. ArchBronconeumol. 2019;55(9):472-477.
28. Ge YL, Zhang HF, Zhang Q, et al. Neutrophil-to-lymphocyte ratioin adult community-acquired pneumonia patients correlates withunfavorable clinical outcomes. Clin Lab. 2019;65(5):839-844.
29. Lee H, Kim I, Kang BH, Um SJ. Prognostic value ofserial neutrophil-to-lymphocyte ratio measurements inhospitalized community-acquired pneumonia. PLoS ONE.2021;16(4):e0250067.
30. Lee JH, Song S, Yoon SY, et al. Neutrophil to lymphocyte ratio andplatelet to lymphocyte ratio as diagnostic markers for pneumoniaseverity. Br J Biomed Sci. 2016;73(3):140-142.
31. Kuikel S, Pathak N, Poudel S, et al. Neutrophil-lymphocyte ratioas a predictor of adverse outcome in patients with community-acquired pneumonia: a systematic review. Health Sci Rep. 2022;5(3):e630.
32. Meng Y, Zhang L, Huang M, Sun G. Blood heparin-bindingprotein and neutrophil-to-lymphocyte ratio as indicators of theseverity and prognosis of community-acquired pneumonia. RespMed. 2023;208:107144. doi.org/10.1016/j.rmed.2023.107144
Article available in :
Volume 4, Issue 6, 2023
Page : 672-677
https://doi.org/10.47582/jompac.1394077
Article Information
Received : 22 Kas 2023
Accepted : 19 Ara 2023
Published : 31 Ara 2023
Corresponding Author :

Mustafa İlteriş Bardakçı: Department of Chest Diseases, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, İstanbul, Turkey

[email protected]
Citation : Bardakcı Mİ, Albayrak GA. Comparison of procalcitonin, C-reactive protein, white blood cell counts and hemogram subparameters in community acquired pneumonia patients. J Med Palliat Care. 2023;4(6):672-677.

Read: -11
Cited: 0
Download : 64
_Footer